Monday, July 27, 2009 3:52:10 PM
the current pr was bleaker than 2 cents but was suprizeingly
better than 1/2 cent at this time. once again communication
skills prove to be lacking. much more detail should be
addressed and at some point all aspects of the current deal
along with an itemized discussion of biph's current structure
needs to be spelled out.
for example, who's left of biophan personell, bsx contract
status, other contract status and details, full disclosure
of the intent of the new MyoCardioCare, Inc, and so on.
the pr leaves much to be desired.
on the other hand, myovad was going nowhere as far as we know,
so new blood may be the fresh kick start needed. the cash
burn will be reduced by rof and going pink. while laying
low in the pinks, bsx royalities could start to flow. all
of this of course under the effect of time.
now again, it is a wait for development which is time, which
is probably dead money with dead company issues. once again
there may be more here than meets the eye while less than
meets the eye is also probable.
i am not pumping biph by any means. i do hold some shares and
have sold some shares.
jmho
biophreakin
palacian
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM